- Sponsored Content
Microplate Based Assay for Misparing of Bispecifics in Cell Culture Samples
BPI Contributor
March 22, 2023
Sponsored by PAIA
This interview features: Sebastian Giehring, CEO, PAIA.
PAIA is presenting the world´s first assay for assessing mispairing of complex biotherapeutics based on charge differences. Mispairing is a huge challenge in the assembly of bispecific antibodies. It refers to the situation where chains from different monoclonal antibodies incorrectly pair with each other, producing process related impurities that have to be monotore during the bioprocess development. PAIA are showing data from one of the first bispecific biosimilars and illustrate the assay principle using standard MAbs with different isoelectric points.
Fill out the form below to download the poster from PAIA.
About the Author(s)
You May Also Like
Upcoming Webcasts
Jun 17 - Jun 20, 2024
Jun 17 - Jun 20, 2024
Our Biopharmaceutical School is the perfect course to gain a well-rounded understanding of the Biopharmaceutical industry. Over three days, you will understand the principle steps in the biopharmaceutical lifecycle, including: raw material selection, up and downstream processes and core technology. Additionally, you will be familiarised with the latest industry trends, including Industry 4.0, and how these are likely to impact the industry’s evolution.
Through a combination of sessions led by experts from the likes of GSK and Pall Biotech, as well as group discussions with your peers, you will learn how to bring a biopharmaceutical drug to market. Each day will be chaired by a different member of the BioProcess International Academy faculty and there will also be time for networking and Q&As with the experts.
Learn More
